Laurent Verkoczy, PhD is Associate Professor of Medicine and Pathology at Duke University Medical Center. Dr.Verkoczy directs the Laboratory of B-cell Immunoregulation at the Duke Human Vaccine Institute and also serves as a B-cell Focus Investigator in Duke’s Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID) consortium. He obtained his Ph.D. in Immunology from the University of Toronto in 2000 and completed post-doctoral studies at The Scripps Research Institute in 2005. His lab seeks to identify impediments limiting protective antibody responses against highly variable pathogens like HIV-1 and aims to test novel immunogens/vaccine strategies to overcome such roadblocks. Recently, to develop a focused setting to evaluate the ability of vaccine candidates to generate HIV-1 broadly neutralizing antibody (bnAb) responses, his group has engineered mouse strains carrying individual unmutated precursors of several rare, but well-characterized B-cell lineages capable of eventually producing bnAbs during HIV-1 infection.
Education and Training
- Ph.D., University of Toronto (Canada), 2000